Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusion.
Phosphaturic Mesenchymal Tumor.
Benson JC, Trejo-Lopez JA, Nassiri AM, Eschbacher K, Link MJ, Driscoll CL, Tiegs RD, Sfeir J, DeLone DR.
AJNR Am J Neuroradiol. 2022 Jun;43(6):817-822. doi: 10.3174/ajnr.A7513. Epub 2022 May 19.
Clinical Characteristics of Malignant Phosphaturic Mesenchymal Tumor Causing Tumor-Induced Osteomalacia.
Abate V, Vergatti A, De Filippo G, Damiano V, Menale C, D'Elia L, Rendina D.
J Clin Endocrinol Metab. 2024 Feb 20;109(3):e1006-e1011. doi: 10.1210/clinem/dgad690.
Tumor-induced Osteomalacia: A Comprehensive Review.
Minisola S, Fukumoto S, Xia W, Corsi A, Colangelo L, Scillitani A, Pepe J, Cipriani C, Thakker RV.
Endocr Rev. 2023 Mar 4;44(2):323-353. doi: 10.1210/endrev/bnac026.
Burosumab for the Treatment of Tumor-Induced Osteomalacia.
Jan de Beur SM, Miller PD, Weber TJ, Peacock M, Insogna K, Kumar R, Rauch F, Luca D, Cimms T, Roberts MS, San Martin J, Carpenter TO.
J Bone Miner Res. 2021 Apr;36(4):627-635. doi: 10.1002/jbmr.4233. Epub 2021 Jan 12.
Malignant phosphaturic mesenchymal tumor of the pelvis: A report of two cases.
Morimoto T, Takenaka S, Hashimoto N, Araki N, Myoui A, Yoshikawa H.
Oncol Lett. 2014 Jul;8(1):67-71. doi: 10.3892/ol.2014.2081. Epub 2014 Apr 22.
Imaging characteristics of phosphaturic mesenchymal tumors.
Gupta A, Kandasamy D, Sharma R, Damle N, Goyal A, Goyal A, Agarwal S, Dharmashaktu Y.
Acta Radiol. 2023 Jun;64(6):2061-2073. doi: 10.1177/02841851231160086. Epub 2023 Mar 13.
Tumor-Induced Osteomalacia.
Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT.
Calcif Tissue Int. 2021 Jan;108(1):128-142. doi: 10.1007/s00223-020-00691-6. Epub 2020 Jun 5.
Imaging features of phosphaturic mesenchymal tumors.
Broski SM, Folpe AL, Wenger DE.
Skeletal Radiol. 2019 Jan;48(1):119-127. doi: 10.1007/s00256-018-3014-5. Epub 2018 Jul 9.
Tumor-induced hypophosphatemia.
Mulani M, Somani K, Bichu S, Billa V.
Indian J Nephrol. 2017 Jan-Feb;27(1):66-68. doi: 10.4103/0971-4065.179302.
[Clinical and immunohistopathologic study of phosphaturic mesenchymal tumor].
Li DM, Wu HW, Li JD, Xia WB, Jiang Y, Zhong DR.
Zhonghua Bing Li Xue Za Zhi. 2018 Jun 8;47(6):427-431. doi: 10.3760/cma.j.issn.0529-5807.2018.06.008.
